Matches in Wikidata for { <http://www.wikidata.org/entity/Q91832096> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q91832096 description "2020 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված" @default.
- Q91832096 description "article scientifique publié en 2020" @default.
- Q91832096 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91832096 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91832096 description "scientific article published on 11 April 2020" @default.
- Q91832096 description "wetenschappelijk artikel" @default.
- Q91832096 description "наукова стаття, опублікована 11 квітня 2020" @default.
- Q91832096 name "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 name "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 type Item @default.
- Q91832096 label "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 label "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 prefLabel "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 prefLabel "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 P1433 Q91832096-CA594608-E2A1-4F31-B345-155885AA21B7 @default.
- Q91832096 P1476 Q91832096-DD68F5D1-FB66-456D-B3A7-D2995D57853A @default.
- Q91832096 P2093 Q91832096-213CB3B3-5D3A-4077-9FFD-DCA283E56001 @default.
- Q91832096 P2093 Q91832096-33B5FEDC-5033-4050-B1CB-5AF12D31AFEE @default.
- Q91832096 P2093 Q91832096-41CF8D9C-2B14-42D3-AD23-49D18A964796 @default.
- Q91832096 P2093 Q91832096-489F9487-5814-4089-9D41-135A9E711560 @default.
- Q91832096 P2093 Q91832096-5CBE33A5-0C3B-4B74-B7A9-5A7FFDB4F8B7 @default.
- Q91832096 P2093 Q91832096-73494F23-3AF1-4D76-8602-727221EDA382 @default.
- Q91832096 P2093 Q91832096-A339EA0F-B166-4C3E-9B87-91D81A1DE2EA @default.
- Q91832096 P2093 Q91832096-D4CFA586-EF75-47DC-A540-A66315C23360 @default.
- Q91832096 P2093 Q91832096-E2CFF5CC-FA55-42BF-862F-2BFBC2EBB951 @default.
- Q91832096 P2093 Q91832096-EABBB381-5E2A-4A2C-B27F-055DAFDFD5DC @default.
- Q91832096 P2093 Q91832096-F999FD05-6545-4420-AAF4-8EC3540ACB1E @default.
- Q91832096 P31 Q91832096-6687D907-0640-4BDB-B6D6-E9A6F650453E @default.
- Q91832096 P356 Q91832096-12CD5122-792E-45A9-967B-82F5D89C1E7D @default.
- Q91832096 P50 Q91832096-6D5EB298-D7FD-404D-AB15-5AB10B68FC2A @default.
- Q91832096 P577 Q91832096-CBA1CF09-7FE7-4317-AE84-C69A1D8DC5AA @default.
- Q91832096 P698 Q91832096-2B89F18E-E24F-4A58-B2E7-67DE75816206 @default.
- Q91832096 P921 Q91832096-A8D05925-9F10-42F7-995F-E0FCD5AB5F78 @default.
- Q91832096 P921 Q91832096-E7ECDE91-01F2-4017-B62C-064953B54AE6 @default.
- Q91832096 P356 S12185-020-02878-X @default.
- Q91832096 P698 32279228 @default.
- Q91832096 P1433 Q6051416 @default.
- Q91832096 P1476 "Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia" @default.
- Q91832096 P2093 "Itaru Matsumura" @default.
- Q91832096 P2093 "Kei Fukuhara" @default.
- Q91832096 P2093 "Kenichi Ishizawa" @default.
- Q91832096 P2093 "Masayuki Hino" @default.
- Q91832096 P2093 "Masayuki Ohkura" @default.
- Q91832096 P2093 "Naohiro Sekiguchi" @default.
- Q91832096 P2093 "Naoto Takahashi" @default.
- Q91832096 P2093 "Shin Fujisawa" @default.
- Q91832096 P2093 "Takaaki Ono" @default.
- Q91832096 P2093 "Yuichiro Koide" @default.
- Q91832096 P2093 "Yusuke Tanetsugu" @default.
- Q91832096 P31 Q13442814 @default.
- Q91832096 P356 "10.1007/S12185-020-02878-X" @default.
- Q91832096 P50 Q87707639 @default.
- Q91832096 P577 "2020-04-11T00:00:00Z" @default.
- Q91832096 P698 "32279228" @default.
- Q91832096 P921 Q729735 @default.
- Q91832096 P921 Q894611 @default.